This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Novmetapharma Co., Ltd., Omic Smap Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Sung Jin Cho
Introduction
Sung Jin Cho is a notable inventor based in Daegu, South Korea. He has made significant strides in the field of pharmaceuticals, particularly in cancer treatment. His work focuses on developing compounds that exhibit high inhibitory abilities on specific enzymes related to cancer progression.
Latest Patents
Sung Jin Cho holds a patent for a Quinazoline-2,4-diamine derivative and a pharmaceutical composition aimed at preventing or treating cancer. This invention includes a compound, a stereoisomer, a hydrate, or a pharmaceutically acceptable salt that demonstrates a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2). The implications of this patent are profound, as it offers a potential avenue for effective cancer treatment.
Career Highlights
Throughout his career, Sung Jin Cho has been associated with Omic Smap Inc., where he has contributed to various innovative projects. His expertise in pharmaceutical development has positioned him as a key figure in his field.
Collaborations
Sung Jin Cho has worked alongside talented colleagues, including Jung Jin Hwang and Sang Eun Park. Their collaborative efforts have further advanced the research and development of new therapeutic solutions.
Conclusion
Sung Jin Cho's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work exemplifies the potential of targeted therapies in combating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile